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Disinfection of drinking water may result in
hundreds of disinfection by-products (DBPs)
(Richardson et al. 2002). Experimental, ani-
mal, and epidemiologic studies provide evi-
dence that a number of these DBPs, including
trihalomethanes, may be associated with
adverse pregnancy outcomes (Balchak et al.
2000; Bove et al. 2002; Gemma et al. 2003;
Goldman and Murr 2002; Plewa et al. 2004;
Ward et al. 2000). However, epidemiologic
studies exploring the effect of drinking water
chlorination and total trihalomethane
(TTHM) exposures on preterm birth in
human populations have reported equivocal
results. When simply comparing treatment
type (i.e., chlorination vs. no chlorination) as a
surrogate for DBP levels, several studies found
increased risks of preterm birth (Kallen and
Robert 2000; Kanitz et al. 1996; Tuthill et al.
1982; Yang 2004; Yang et al. 2000), but one
reported negative associations, suggesting pro-
longed rather than shortened gestation in
exposed subjects (Jaakkola et al. 2001). Studies
that relied on quarterly TTHM measurements
in water systems for exposure assessment also
reported mixed results. A Massachusetts study
found a small decrease in risk of preterm birth
among women who experienced high second-
trimester or total pregnancy exposure to
TTHM, but no association was observed for
third-trimester exposures (Wright et al.
2003). However, in a second study, the same
authors found that third-trimester exposures
apparently decreased the risk of delivering a
preterm infant (Wright et al. 2004). A New
Jersey study reported a slightly increased risk
for preterm births with high average expo-
sures to TTHM throughout pregnancy, but
the effects were nonlinear (Bove et al. 1992).
This group also estimated stronger effects on
preterm births in women whose drinking
water originated from surface rather than
groundwater. Finally, studies conducted in
Arizona, North Carolina, Iowa, Colorado,
and Canada have not found associations
between preterm births and elevated levels of
TTHM ( Dodds et al. 1999; Gallagher et al.
1998; Hinckley et al. 2005b; Kramer et al.
1992; Savitz et al. 1995).
For water systems serving > 10,000 people
in the United States, regulatory monitoring
data consist of samples taken at four sites and
typically collected quarterly; thus, these data
may not accurately capture spatiotemporal
variability in DBPs [U.S. Environmental
Protection Agency (EPA) 1998]. Previous epi-
demiologic studies of preterm birth relying on
such data for exposure assessment thus neces-
sarily operated at a relatively crude time scale.
In this study, we were able to improve the
time scale by employing weekly monitoring
data for TTHMs. In addition, we decreased
heterogeneity in TTHM across water distribu-
tion systems by relying on only a single public
utility serving multiple communities in
Massachusetts. Specifically, the water treat-
ment regimens employed by this utility mini-
mized the geographic variability of TTHMs.
The importance of such a feature for valid
exposure assessment in epidemiologic studies
is underscored by recent research to develop
methods to identify utilities that have low spa-
tial variability of DBP (Hinckley et al. 2005a). 
Linking 2 years of birth data to weekly
monitoring data for TTHMs enabled us to
model the associations between shorter-term
peak exposures and preterm births. Unlike
most previous research, in our study we
matched cases and controls closely on gesta-
tional age at exposure to address the inﬂuence
of exposure timing—the existence of vulnera-
ble windows late in pregnancy. Finally, our
study population is diverse and large enough
to allow us to examine the relation between
preterm births and TTHM in the water sup-
plied to homes for different racial/ethnic and
socioeconomic groups.
Materials and Methods
Data were obtained from the Registry of Vital
Records and Statistics, Massachusetts
Department of Public Health (Boston, MA).
We abstracted 39,593 records of singletons
conceived between the beginning of February
1999 and the end of February 2001 whose
mothers, at the birth of their child, resided in
a community served only by the utility stud-
ied. This 2-year period represented the time
during which complete exposure during preg-
nancy could be ascertained for all preterm
and term births. We restricted our analyses to
infants between 32 and 45 gestational weeks
with a birth weight between 500 and 5,000 g
(n = 905 excluded). Furthermore, if the birth
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of the following variables, subjects were
excluded from the analyses: sex, maternal age,
marital status, race-ancestry, maternal educa-
tion, parity, cigarette smoking, payment
source, or a maternal disease factor (n = 1,190
excluded), leaving us with 37,498 births.
Cases were deﬁned as preterm birth or infants
born at < 37 completed weeks of gestation,
calculated from date of last menstrual period
(LMP) provided in the birth ﬁle. Cases were
matched to controls by gestational age; thus,
controls were still unborn at the gestational
time the preterm births occurred. 
Water quality data. We abstracted tri-
halomethane data from the Massachusetts
Department of Environmental Protection
(MDEP 2003) records for 27 communities
receiving water from a single supplier.
Trihalomethane concentrations were deter-
mined by U.S. EPA method 524.2 (Sung et al.
2000; U.S. EPA 1995) and consisted of chlo-
roform, bromoform, bromodichloromethane,
and dibromochloromethane. The sum of
measurements for all constituents represents
our measure of TTHM. The details of the
water treatment and distribution are provided
elsewhere (Lewis et al. 2006; Sung et al. 2000). 
Exposure assessment. We employed data
on maternal residence at birth, gestational age,
and environmental sampling to create a total
TTHM exposure estimate for each gestational
period. For each infant we calculated exposure
measures of average TTHM for the ﬁrst (ges-
tational days 1–93), second (gestational days
94–186), and third trimester (gestational days
187–280), and 4, 2, and 1 weeks before birth
for both cases and unborn controls matched
by gestational age to each case. Relying on
weekly TTHM samples, we calculated each
mother’s average exposure for the aforemen-
tioned time frames for the maternal residence
reported on the birth certiﬁcate. In the follow-
ing, we consider TTHM exposures averaged
over 1 week to 1 month, rather than a whole
trimester or all of pregnancy, as “peak” expo-
sures. Pregnancy length in days was calculated
by multiplying the LMP gestational age, pre-
sented in weeks, by seven, thus assuming the
value represented completed weeks of gesta-
tion (Lewis et al. 2006). The weekly average
TTHM of four sampling sites was applied to
24 of 27 communities as described in our pre-
vious publication (Lewis et al. 2006). Initially
we considered exposure categories in 10-µg/L
increments, but it became necessary to col-
lapse categories to improve estimation. While
doing so, we tried to maintain consistency
with our prior publication and cut points used
in previous research (Lewis et al. 2006). 
Statistical methods. We employed risk sets
(Breslow and Day 1987) to control for timing
(gestational age) of exposure to TTHM during
the third trimester and to hold the duration of
exposure constant. For example, if a preterm
birth occurred during the 32nd week of gesta-
tion, controls comprised all children still in
the womb during week 32; thus, both cases
and controls had a TTHM 4-week average
exposure that spanned from week 28 to 31 of
gestation. Indicator variables were used for
infant sex, marital status (married, not mar-
ried, and previously married within 300 days),
adequacy of prenatal care (Kessner Index)
(Kessner et al. 1973), maternal age (< 20,
20–29, 30–34, 35–39, or ≥ 40 years of age),
maternal race/ethnicity (African American,
Asian, Caucasian, Hispanic, or other), mater-
nal education (< high school, high school
degree, associate’s degree, bachelor’s degree, or
postgraduate), interval since the previous live
birth (≤ 12 months or > 12 months), maternal
smoking during pregnancy (0, 1 to 5, 6 to 10,
or ≥ 11 cigarettes/day), previous infant weigh-
ing > 4,000 g, previous preterm or small-for-
gestational-age (SGA) infant, prenatal care
source of payment (private, Healthy Start, or
government), conception season (i.e., four
periods of 3 months’ length), birth season, and
community per capita income taken from
U.S. Census Bureau data (< $23,000, $23,000
to < $26,000, $26,000 to < $33,000, or
≥ $33,000) (U.S. Census Bureau 2001). A sin-
gle indicator variable was created to indicate
the presence of one or more of the following
maternal diseases during pregnancy: diabetes,
eclampsia, hydramnios, chronic hypertension,
lung disease, pregnancy-related hypertension,
incompetent cervix, lupus, renal disease, uter-
ine bleeding, and inappropriate weight
gain/loss. Our final models contain all listed
potential risk factors for preterm birth reported
on birth certiﬁcates including 11 of 21 mater-
nal diseases experienced during pregnancy (10
diseases did not influence results or were
extremely rare). We conducted analyses strati-
ﬁed by some of our individual- and commu-
nity-level indicators for socioeconomic status
(SES) to examine effect measure modiﬁcation.
SES strata were defined as “low” if prenatal
care source of payment was Healthy Start or
government, per capita income was < $26,000,
or maternal education was an associate’s degree
or less; and deﬁned as “high” if the payment
source was private, community per capita
income was > $26,000, or maternal education
was a 4-year degree or more. 
Results
A total of 894 trihalomethane samples were
abstracted for six monitoring sites from 1999
through 2001. The interquartile range of the
monthly TTHM distributions was 59 µg/L
(minimum = 28 µg/L; maximum = 87 µg/L).
The timing and duration of the TTHM peaks
varied each year, sometimes occurring as early
as May or as late as August. The main com-
ponent of TTHM in this water system was
chloroform, contributing 83–93% of the
TTHM (average, 89%) to the monthly average
fraction. Bromodichloromethane ranged from
not detected to 9 µg/L (75th percentile, 6.1
µg/L). Dibromochloromethane and bromo-
form were not detectable or were measured at
very low levels (< 1 µg/L) (Lewis et al. 2006).
The mean birth weight of the 37,498
infants included in our analysis was 3,405 g.
Among these infants, 2,813 (7.5%) were clas-
sified as preterm births. The distributions of
major predictors and TTHM exposure esti-
mates for preterm births are shown in Tables 1
and 2. In general, mothers who were ≤ 20 or
> 40 years of age, African American or
Hispanic, lacked adequate prenatal care, or
suffered from a disease during pregnancy were
more likely to deliver preterm. The percent of
preterm births declined with increasing
TTHM exposure during the second trimester. 
Preterm births. For all women, our data
were consistent with a decrease in the risk of
preterm births for high levels of TTHM
(≥ 60 µg/L) exposure during the second
trimester [hazard ratio (HR) = 0.82; 95%
conﬁdence interval (CI), 0.71–0.94] and also
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Table 1. Demographic characteristics of mothers and
their singleton infants in selected Massachusetts
communities served by a single surface–supplied
drinking water utility, 1999–2001.
Study Percent 
population preterm 
Characteristic [no. (%)] (n = 2,813)
Total 37,498 (100) 7.5
Sex 
Male 19,219 (51.3) 7.8
Female 18,279 (48.7) 7.1
Age (years)
< 20 2,136 (5.7) 9.2
20 to 29 13,937 (37.2) 7.7
30 to 34 12,671 (33.8) 6.9
35 to 39 7,144 (19.1) 7.5
≥ 40 1,610 (4.3) 8.3
Race
Caucasian 21,945 (58.5) 6.5
African American 5,846 (15.6) 10.4
Hispanic 5,957 (15.9) 9.1
Asian 3,716 (9.9) 6.3
Other 34 (0.1) 8.8
Prenatal carea
Adequate 27,941 (74.5) 7.0
Intermediate 4,995 (13.3) 9.9
Inadequate 992 (2.6) 10.7
No prenatal care 48 (0.1) 25.0
Unknown 3,522 (9.4) 7.2
Parity
1 18,235 (48.6) 7.9
2 to 3 16,883 (45.0) 6.8
4 to 5 2,069 (5.5) 9.5
≥ 6 311 (0.8) 9.3
Maternal disease factor present
None 31,556 (84.2) 6.5
≥ 1 5,942 (15.8) 12.9
Prenatal care payment source
Private or HMO 25,708 (68.6) 6.6
Government or  11,790 (31.4) 9.6
Healthy Start
aKessner Index (Kessner et al. 1973)during the whole of pregnancy (HR = 0.85;
95% CI, 0.74–0.97). A negative trend was
observed per 10-µg/L increase in TTHM for
both exposure-averaging periods (Table 3). 
In contrast, there was a weak association
between previous-4-weeks high exposure to
TTHM and preterm birth (HR = 1.13; 95%
CI, 0.95–1.35) (Table 3), but the estimate was
relatively imprecise. Results were similar for
the highest TTHM levels averaged over only
2 weeks and 1 week before birth (HR 1.15;
95% CI, 0.97–1.35 2-week average; and HR
1.06; 95% CI, 0.92–1.23 1-week average)
(data not shown). 
When examining the inﬂuence of TTHM
exposure by maternal race/ethnicity, we found
that high exposures (≥ 60 µg/L TTHM) expe-
rienced during the second trimester were nega-
tively associated with preterm birth, most
strongly in African Americans (HR = 0.62;
95% CI, 0.46–0.84), possibly Asians (HR =
0.72; 95% CI, 0.44–1.20), and to a lesser
degree in Caucasians (HR = 0.86; 95% CI,
0.71–1.05), but was not associated with
preterm birth in Hispanic women (Table 3).
Associations were also observed between previ-
ous-4-weeks medium and high exposure to
TTHM and preterm birth among Hispanic
women (Table 3). When we stratiﬁed our data
by payment source as an indicator of maternal
SES, negative trends and a decrease in risk at
high levels of second-trimester exposure were
observed for both low- and high-SES women
(Table 4). 
Preterm birth was also associated with
high levels of exposure to TTHM (≥ 60 µg/L)
experienced during the last 4 weeks before
birth by women with a government source of
payment for prenatal care (HR = 1.39; 95%
CI, 1.06–1.81) (Table 4). Inclusion of an
interaction term between TTHM exposure
and source of prenatal care marginally
improved the ﬁt of the model (p = 0.12) (data
not shown). The point estimates for low-SES
mothers increased when the analyses were
restricted to gestational ages < 36 weeks (HR =
1.49; 95% CI, 1.04–2.13) or < 35 weeks (HR
= 1.67; 95% CI, 1.01–2.74) (data not shown).
Increased risk of preterm birth was also associ-
ated with high TTHM during the last 4 weeks
before birth in women categorized as having
low per capita income (< $26,000) (HR =
1.19; 95% CI, 0.97–1.46) and in women with
an associate’s degree or less (HR = 1.14; 95%
CI, 0.91–1.41), but the estimated effect sizes
were smaller than those for source of payment.
Discussion 
We relied on information from birth certifi-
cates and TTHM data sampled at high
frequency to construct risk sets (Breslow and
Day 1987) and derive gestational age–
matched TTHM exposure measures for resi-
dents of Massachusetts communities served by
a single public utility. Our results were consis-
tent with those of an earlier Massachusetts
study that reported a decrease in risk of
preterm delivery when mothers experienced
high exposures during the second trimester
(Wright et al. 2003). However, our results
were also consistent with a possible increase in
risk of delivering preterm when TTHM levels
were high 4 weeks before delivery in the third
trimester for mothers who had to rely on a
government source of payment for prenatal
care. Equivocal and inconsistent results from
previous epidemiologic research on TTHMs
and preterm births may be attributable to sev-
eral factors, including the lack of controlling for
timing and duration of exposure among cases
and controls when estimating third-trimester
effects, a lack of examining susceptible sub-
groups, crude/biased exposure assessments, and
lack of control for exposures received before
the third trimester. 
To date, no other published study has
described an increased risk of preterm birth
and TTHM exposure during the short period
before delivery while matching on gestational
age (Hinckley et al. 2005b). We explored 4-,
2-, and 1-week time windows of exposure
before preterm delivery but found little differ-
ence between effect estimate sizes, suggesting
that it is not a very short-term acute effect of
exposure. We examined the potential impact
of inaccurately assigned gestational age by
shortening the gestational age for our case def-
inition to 35 and 34 weeks and found that
effect estimates were similar to those for
32–36 weeks, or even increased. The increased
risk observed among Hispanic women lacks a
dose–response pattern, and the diversity of the
Massachusetts Hispanic population renders
interpretation difﬁcult; but research has shown
demographic variables to be strongly predic-
tive of use and consumption of water (Forssén
et al. 2006). We did not evaluate an inter-
action term for ethnic group and TTHM.
Although there was suggestion of an inter-
action between ethnic group and TTHM, our
sample size was insufficient to estimate this
Lewis et al.
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Table 2. Study population and percent preterm
births by TTHM (µg/L) level averaged over different
gestational periods.
Study Percent
population preterm 
TTHM (µg/L) [no. (%)] (n = 2,813)
Total 37,498 (100) 7.5
First trimester
< 40 10,831 (28.9) 7.2
40 to < 60 17,588 (46.9) 7.6
≥ 60 9,079 (24.2) 7.7
Second trimester
< 40 10,604 (28.3) 7.9
40 to < 60 16,059 (42.8) 7.5
≥ 60 10,835 (28.9) 7.2
Previous 4-week average
< 40 10,300 (27.5) 8.2
40 to < 60 13,031 (34.8) 7.1
≥ 60 14,167 (37.8) 7.4
Pregnancy average
< 40 7,222 (19.3) 8.2
40 to < 60 21,399 (57.1) 7.3
≥ 60 8,877 (23.7) 7.4
Table 3. Adjusteda HRs (95% CIs) for preterm birth and gestational age-speciﬁc TTHM exposure averages
by race and ancestry. 
TTHM (µg/L) 1st Trimester 2nd Trimester 4-Week risk sets Pregnancy average
All races (n = 2,813)
< 40 1.00 1.00 1.00 1.00
40 to < 60 1.02 (0.92–1.13) 0.87 (0.77–0.99) 1.00 (0.87–1.15) 0.92 (0.82–1.02)
≥ 60 1.00 (0.88–1.14) 0.82 (0.71–0.94) 1.13 (0.95–1.35) 0.85 (0.74–0.97)
Per 10 µg/L 0.98 (0.95–1.02) 0.95 (0.92–0.99) 1.01 (0.97–1.06) 0.95 (0.91–0.99)
Caucasians (n = 1,429)
< 40 1.00 1.00 1.00 1.00
40 to < 60 0.97 (0.84–1.12) 0.93 (0.77–1.11) 0.97 (0.79–1.18) 0.92 (0.79–1.06)
≥ 60 1.04 (0.87–1.24) 0.86 (0.71–1.05) 1.14 (0.90–1.45) 0.81 (0.67–0.99)
Per 10 µg/L 0.99 (0.94–1.05) 0.95 (0.90–1.00) 1.04 (0.97–1.10) 0.96 (0.91–1.03)
African American (n = 607)
< 40 1.00 1.00 1.00 1.00
40 to < 60 1.27 (1.00–1.60) 0.73 (0.56–0.96) 0.78 (0.57–1.07) 0.95 (0.74–1.20)
≥ 60 1.13 (0.84–1.52) 0.62 (0.46–0.84) 1.00 (0.69–1.45) 0.77 (0.57–1.05)
Per 10 µg/L 1.01 (0.93–1.10) 0.89 (0.82–0.96) 0.98 (0.89–1.08) 0.90 (0.81–0.99)
Hispanic (n = 541)
< 40 1.00 1.00 1.00 1.00
40 to < 60 0.97 (0.75–1.24) 1.07 (0.80–1.43) 1.59 (1.15–2.21) 0.87 (0.68–1.12)
≥ 60 0.86 (0.63–1.17) 1.07 (0.78–1.46) 1.63 (1.09–2.43) 1.00 (0.73–1.36)
Per 10 µg/L 0.95 (0.87–1.04) 1.04 (0.96–1.14) 1.05 (0.95–1.17) 1.01 (0.91–1.11)
Asian (n = 233)
< 40 1.00 1.00 1.00 1.00
40 to < 60 0.94 (0.65–1.34) 0.65 (0.42–1.02) 0.80 (0.49–1.29) 0.89 (0.62–1.26)
≥ 60 0.77 (0.49–1.22) 0.72 (0.44–1.20) 0.68 (0.35–1.29) 0.86 (0.54–1.37)
Per 10 µg/L 0.90 (0.79–1.03) 0.95 (0.82–1.09) 0.88 (0.74–1.04) 0.86 (0.74–1.01)
aHRs were adjusted for infant sex, marital status, adequacy of prenatal care, maternal age, maternal race/ethnicity,
maternal education, parity, maternal smoking, prenatal care source of payment, conception season, birth season, per-
capita income, previous preterm or SGA infant, previous trimester TTHM exposure, and the presence of one or more
maternal disease factors including lung disease, diabetes, eclampsia, hydramnios, chronic hypertension, pregnancy-
related hypertension, incompetent cervix, renal disease, uterine bleeding, and inappropriate maternal weight gain/loss. interaction with precision, and our results
were also consistent with effect homogeneity
across ethnic groups. 
Our negative effect estimates for the sec-
ond trimester and pregnancy overall are con-
sistent with research by Wright et al. (2003),
who reported reduced risk for second
trimester [odds ratio (OR) = 0.90; 95% CI,
0.79–1.03] and pregnancy average (OR =
0.90; 95% CI, 0.77–1.04) exposure > 80
µg/L TTHM compared with < 60 µg/L. The
authors (Wright et al. 2003) also provide evi-
dence of a positive trend with length of gesta-
tional age—higher TTHM exposure and
increasing gestational length. Previously, we
reported a second-trimester DBP association
with fetal growth that may differ by race/eth-
nicity (Lewis et al. 2006). Thus, our current
results suggest a mirror-image TTHM effect
in opposite directions for growth retardation
and preterm birth. A possible explanation
might be that high exposure to TTHM dur-
ing the second trimester may prolong preg-
nancy through mechanisms that may also
restrict fetal growth and thus result in small
babies born at term. 
Recent research exploring the influence
of cytokines on preterm and SGA birth
may provide some support for this explana-
tion (Engel et al. 2005). Polymorphisms in
pro-inflammatory cytokines [i.e., tumor
necrosis factor (TNF)] have been associated
with preterm births (Crider et al. 2005; Engel
et al. 2005), whereas polymorphisms in anti-
inﬂammatory cytokines [i.e., interleukin (IL)-
4] have been associated with SGA outcomes
(Engel et al. 2005). In animals, both of these
cytokines may be affected by exposure to car-
bon tetrachloride, a haloalkane similar to chlo-
roform, and to phosgene, a metabolite of
chloroform (Sciuto et al. 2003; Weber et al.
2003). Engel et al. (2005) outlined a concep-
tual model of how a perturbation in the bal-
ance of pro- and anti-inﬂammatory cytokines
during pregnancy may determine the time of
delivery and result in preterm or SGA birth.
Specifically, these authors suggested that a
decreased production of anti-inflammatory
cytokines may increase the risk of spontaneous
preterm birth but decrease the risk of SGA,
whereas an increased production of anti-
inﬂammatory cytokines may increase the risk
of SGA (Engel et al. 2005). Elevated levels of
both pro-inﬂammatory (TNF, IL-6, IL-8) and
anti-inflammatory (IL-10; transforming
growth factor) cytokines have also been identi-
ﬁed in animals exposed to carbon tetrachloride
(Weber et al. 2003). In addition, mice
exposed to phosgene exhibited increased levels
of pro-inﬂammatory cytokines IL-6, TNF-α,
IL-1β, macrophage inflammatory protein-2,
and anti-inflammatory cytokine IL-10, but
decreased levels of IL-4 (Sciuto et al. 2003). It
is therefore possible that timing of and weight
at birth may depend on the balance of these
cytokines. Exposure to DBPs may alter that
balance depending on the baseline state of the
mother (biologic and genetic susceptibility)
and the timing of exposure. 
However, our results could also reﬂect an
effect of DBPs on fetal death. In our study, we
focused on the association between DBPs and
preterm birth among live-born infants only. If
high second-trimester levels of DBPs were to
cause fetal death among vulnerable concep-
tuses—that is, those conceptuses who were at
greatest risk for preterm birth due to other fac-
tors—then among survivors DBPs might
appear to be inversely associated with preterm
birth. This phenomenon reflects a type of
selection bias inherent in studies of birth out-
comes (Hernan et al. 2002, 2004). We exam-
ined the plausibility of this selection bias by
estimating whether there was a sufﬁcient num-
ber of highly exposed (TTHM ≥ 60 µg/L)
fetal deaths to modify observed ORs of
preterm births. Using aggregate monthly data,
we estimated the range of fetal deaths that
would have experienced an elevated 4-week
average TTHM exposure (i.e., ≥ 60 µg/L and
≥ 70 µg/L) during the month of death as well
as lags of 1, 2, and 3 months before the death.
This approach resulted in a range of 71–103
highly exposed fetal deaths during the study
period. When these numbers (71 fetal deaths)
were added to the number of highly exposed
preterm births, the OR estimate changed from
negative (OR = 0.90; 95% CI, 0.81–1.00) to
null (OR = 0.98; 95% CI, 0.89–1.09).
Therefore, selection bias cannot be ruled out
as a possible explanation for the negative
associations observed here and in previous
research, although recent research suggests
that DBPs in the range commonly encoun-
tered in the United States may not affect sur-
vival (Savitz et al. 2006). 
SES is a complex concept that has been
associated with a range of diseases. We
explored individual- and community-level
indicators of SES and found that source of
payment for prenatal care and less clearly a
combination of per capita income at the com-
munity level and maternal education as an
indicator of SES may modify the risk of
preterm birth due to shorter-term TTHM
exposures [high TTHM exposures (≥ 60
µg/L)] during the last 4 weeks before birth: low
SES: HR = 1.25; 95% CI, 0.94–1.65; high
SES: HR = 0.97; 95% CI, 0.65–1.44; govern-
ment source of prenatal care: HR = 1.39; 95%
CI, 1.06–1.81; and private source of payment
for prenatal care: HR = 1.00; 95% CI,
0.79–1.25. It is possible that the indicators of
low SES serve as a proxy for an increased bio-
logic susceptibility to toxicants or reﬂects actual
differences in exposure by SES. Low-SES
women may be more susceptible to TTHM
exposures during the third trimester (i.e.,
shortly before normal delivery) because they
already experience higher levels of other envi-
ronmental or social stressors, increasing their
vulnerability in general (Perera et al. 2004). In
addition, low-SES women may not receive the
same medical attention as other women when
they experience signs of preterm labor and
thus may be at increased risk of preterm birth.
Compared with mothers with private [i.e.,
HMO (health management organization)]
sources of payment for prenatal care, the
mothers with a government source of pay for
prenatal care were young, had a high school
education or less, and lacked adequate prenatal
care based on the Kessner Index. We do not
believe that SES differences resulted in differ-
ences of TTHM concentrations at the resi-
dence because TTHMs exhibited little
intrasystem variability during our study period
in general. 
Our models included previous trimester
exposure—HRs for prior 4 weeks exposures
were adjusted for first- and second-trimester
TTHM exposure. When we estimated effects
for 4 weeks before birth during the third
trimester ignoring previous exposures, we did
not find any effects at high exposure (i.e.,
TTHM ≥ 60 µg/L): HR = 0.99; 95% CI,
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Table 4. Crude and adjusteda HRs (95% CIs) for preterm birth and gestational age speciﬁc TTHM exposure
averages by payment source for prenatal care.
2nd Trimester 4 Weeks before birth
TTHM (µg/L) Governmentb (n = 1,129) Privatec (n = 1,684) Governmentb (n = 1,129) Privatec (n = 1,684)
Crude
< 40 1.00 1.00 1.00 1.00
40 to < 60 0.88 (0.75–1.02) 0.92 (0.81–1.04) 1.01 (0.84–1.23) 0.92 (0.79–1.08)
≥ 60 0.84 (0.71–0.99) 0.88 (0.77–1.01) 1.19 (0.98–1.44) 0.94 (0.80–1.10)
Adjusted
< 40 1.00 1.00 1.00 1.00
40 to < 60 0.88 (0.72–1.07) 0.87 (0.74–1.03) 1.07 (0.85–1.34) 0.96 (0.80–1.15)
≥ 60 0.83 (0.67–1.04) 0.82 (0.69–0.99) 1.39 (1.06–1.81) 1.00 (0.79–1.25)
Per 10 µg/L 0.96 (0.91–1.02) 0.95 (0.90–1.00) 1.03 (0.96–1.11) 1.00 (0.95–1.06)
aHRs were adjusted for infant sex, marital status, adequacy of prenatal care, maternal age, maternal race and ancestry,
maternal education, parity, maternal smoking, conception season, birth season, per-capita income, previous preterm or
SGA infant, previous-trimester TTHM exposure, and the presence of one or more maternal disease factors including lung
disease, diabetes, eclampsia, hydramnios, chronic hypertension, pregnancy-related hypertension, incompetent cervix,
renal disease, uterine bleeding, and inappropriate maternal weight gain/loss. bSource of payment was government or
Healthy Start. cSource of payment was private or health maintenance organization. 0.87–1.14; government source of prenatal care:
HR = 1.14; 95% CI, 0.92–1.14; private source
of payment for prenatal care: HR = 0.92; 95%
CI, 0.77–1.09. Thus, effect estimates for
TTHM exposure during the previous 4 weeks
before birth may be confounded by previous
trimester exposures. However, second-
trimester effects continued to be negative at
high-TTHM exposure whether or not we
adjusted for first-trimester exposures (HR =
0.86; 95% CI, 0.76–0.97). Adjusting for pre-
vious trimester exposure assumes that expo-
sures and health impacts from conception
through birth are part of a continuous process
and that exposures experienced during an ear-
lier period may alter the effect these exposures
have during a later period (Selevan and
Lemasters 1987; Weinberg and Wilcox 1998). 
We were able to use more frequently sam-
pled monitoring data in communities served
by one utility during a period in which treat-
ment regimens and raw water quality created
seasonally variable but spatially stable intrasys-
tem TTHMs, as described previously (Lewis
et al. 2006). Not only does the use of weekly
monitoring data capture temporal peaks in
TTHM better than quarterly data, but our
approach resulted in studying a population’s
exposure over time rather than comparing pop-
ulations from different communities with vary-
ing exposure levels to each other. Thus, we
reduced the risk of confounding by geographic
and demographic risk factors, because there are
far fewer time-varying risk factors we are aware
of that might correlate with TTHM levels and
thus confound our risk estimates. Improved
exposure assessment also is likely to reduce the
potential for exposure misclassiﬁcation.
We used maternal address at birth to
assign exposures, assuming that this was the
residence for the entire pregnancy. Research
indicated that a substantial number (25%) of
women are likely to move between conception
and delivery, although most of these women
move within the county of residence (Khoury
et al. 1988; Shaw and Malcoe 1992). We do
not believe that a large percentage of women
moved out of the water service area we studied
because 24 communities in our study area
were adjacent to each other, as described else-
where (Lewis et al. 2006). For women who
move into the water service area during preg-
nancy, we would expect that moving is not
affected by (subsequent) outcome status, and
therefore estimates would likely be affected by
nondifferential exposure misclassification.
However, the direction of bias is difficult to
predict without a quantitative assessment. 
As in previous studies, we were unable to
distinguish between various pathways of
exposure. Substantial exposure to the volatile
portion of DBPs might occur through dermal
contact and inhalation during showering,
bathing, swimming, and hand dishwashing
but we were unable to measure the contribu-
tion of such exposures in this study (Nuckols
et al. 2005). 
There is a possibility of residual
confounding in our study because of lack of
information on selected risk factors such as
maternal nutrition, job-related risk factors,
maternal infection rates, indoor/outdoor air
pollution, and other water contaminants.
However, these risk factors would have to be
associated with TTHM exposure levels to act
as confounders—that is, they would have to
be varying over time in concert with the vari-
ation of TTHM levels. Although air pollu-
tion is time varying and could be a potential
confounder, the air pollutants most often
linked to preterm birth in the literature are
combustion by-products (i.e., sulfur dioxide)
and would be expected to be highest in win-
ter (Maisonet et al. 2001). This is anticyclical
to TTHM levels, which tend to increase with
water’s ultraviolet-254 absorbance and tem-
perature (Sung et al. 2000). Thus, we would
expect negative confounding of our associa-
tions, if any. The same would be true for
maternal respiratory infections, whereas
nutrition and job-related factors are likely
not seasonal in the population studied.
Conclusion
In contrast to previous studies, we used risk-
set matching in our case–control study of
preterm births and obtained results consistent
with a negative association for second-
trimester TTHM exposure and a possible
positive association with shorter-term third-
trimester TTHM exposure in mothers of low
SES. Future research on preterm births and
DBPs should employ survival analysis meth-
ods when estimating third-trimester effects,
adjust for exposure received in all three
trimesters, and if at all possible investigate risk
in susceptible subgroups—that is, investigate
the influence of race/ethnicity and SES in
conjunction with exposures on the outcomes.
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